|Nome||Titolo||Retribuzione||Esercitate||Anno di nascita|
|Mr. Stefan A. Dräger B.A.||Chairman of the Exec. Board - Drägerwerk Verwaltungs AG||1,94M||N/D||1963|
|Mr. Gert-Hartwig Lescow||CFO, Exec. Board Member for IT & Vice Chairman of Exec. Board - Drägerwerk Verwaltungs AG||1,28M||N/D||1967|
|Mr. Anton Schrofner||Chief Medical Officer & Member of Exec. Board - Drägerwerk Verwaltungs AG||909,12k||N/D||1963|
|Mr. Rainer Klug||Chief Security Officer & Member of Exec. Board - Drägerwerk Verwaltungs AG||767,67k||N/D||1968|
|Dr. Reiner Piske||Chief Sales and HR Officer & Member of Exec. Board - Drägerwerk Verwaltungs AG||902,62k||N/D||1970|
Drägerwerk AG & Co. KGaA operates as medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, generic and device-specific consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems and interchangeable special units for tunnel rescue trains. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.
L'ISS Governance QualityScore di Dragerwerk AG & Co. KGaA al 7 dicembre 2019 è 9. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 4; diritti degli azionisti: 7; retribuzione: 10.